• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Economy Socio Economic

COVID-19: WHO awaits full clinical data on Merck’s antiviral pill

Chidinma Anyalewechi by Chidinma Anyalewechi
October 12, 2021
in Socio Economic
Australia to buy 300,000 Merck’s Covid-19 capsule as cases hit record high
Share on FacebookShare on TwitterShare on Linkedin

The World Health Organization is awaiting full clinical data on the antiviral pill made by Merck & Co. Inc to treat mild-to-moderate COVID-19 patients and reduce the rate of hospitalizations.

This was announced by a WHO spokesperson today, a day after the company said it had applied for U.S. emergency use authorisation, according to Reuters.

In response to questions asked at a U.N briefing in Geneva, the WHO spokesperson, Christian Lindmeier, said, “Indeed, this is an interesting development. We would have to see the full data about it. If it holds true, then it is another weapon in the fight against the COVID-19 pandemic.”

RelatedStories

Global leaders pledge over $170 million to WHO in push for sustainable health financing 

Global leaders pledge over $170 million to WHO in push for sustainable health financing 

May 21, 2025
WHO nominates Prof. Mohamed Janabi as regional director for Africa 

WHO nominates Prof. Mohamed Janabi as regional director for Africa 

May 19, 2025

What this means

Molnupiravir, the pill produced by Merck & Co Inc, is expected to reduce the rate of hospitalisation and death from Covid-19 by 50% in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease.

However, Former U.S Commissioner for Foods and Drugs, Dr. Scott Gottlieb has explained why he’s optimistic about Merck’s Covid antiviral pill after the drugmaker applied for emergency use authorization to the Food and Drug Administration to treat people with mild to moderate Covid symptoms.

He says, “The topline data from this Merck study was probably the best treatment effect we’ve seen from orally available antiviral drug in the treatment of any respiratory pathogen, so this can make a real difference”.

The Merck pill is the first of its kind and if the emergency use authorization is given on the drug, it will be the first pill shown to work against Covid-19 and could be available to Americans by the end of the year.

Gottlieb commented on Merck’s pill, stating that it is part of an “overall, significant improvement in our therapeutic toolbox against this virus, not just with vaccines and therapeutics, but also with more accessible diagnostic tests.”

“We’ve seen sharp declines in the south, where delta’s largely run its course, so cases are coming down very sharply in populous states like Texas and Florida, but you’re seeing pretty dense epidemics in the midwest and plain states, and we still don’t know how the northeast and the northern states are going to fare,” he said.

He further predicts that a Covid-19 delta wave could hit northern U.S. states, despite the higher vaccination rates and higher prior infection rates.

Tags: Covid-19MolnupiravirWHOWorld Health Organization
Chidinma Anyalewechi

Chidinma Anyalewechi

For further inquiries about this article, contact: Email: chidinma.anyalewechi@nairametrics.com LinkedIn: linkedin.com/in/chidinma-anyalewechi-a323ab173/

Related Posts

Global leaders pledge over $170 million to WHO in push for sustainable health financing 
Health

Global leaders pledge over $170 million to WHO in push for sustainable health financing 

May 21, 2025
WHO nominates Prof. Mohamed Janabi as regional director for Africa 
Health

WHO nominates Prof. Mohamed Janabi as regional director for Africa 

May 19, 2025
Nurses to account for 66% of Africa’s projected shortfall of 6.1 million health workers by 2030 – Ihekweazu 
Health

Nurses to account for 66% of Africa’s projected shortfall of 6.1 million health workers by 2030 – Ihekweazu 

May 10, 2025
WHO, MPP partner with Nigerian firm for local manufacturing of rapid diagnostic tests in Africa 
Health

WHO, MPP partner with Nigerian firm for local manufacturing of rapid diagnostic tests in Africa 

May 9, 2025
mpox
Health

Africa requires over $220 million to sustain Mpox response – Africa CDC, WHO 

April 17, 2025
USAID places all staff globally on administrative leave from February 7, 2025 
Health

USAID withdrawal will disrupt essential services in northeast Nigeria – Stakeholders warn 

March 30, 2025
Next Post
Celsius Network raises $400 million as valuation puts the company at more than $3 billion

Celsius Network raises $400 million as valuation puts the company at more than $3 billion

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Emple
nlng
first bank
Zenth Bank








DUNS

Recent News

  • CBN suspends dividends, bonuses, and foreign investments for banks under regulatory forbearance 
  • EFCC arraigns SunTrust Bank MD, Executive Director over alleged $12 million money laundering 
  • Cornerstone Insurance declares 27 kobo final dividend, reveals payment date and criteria 

Follow us on social media:

Recent News

CBN, forex

CBN suspends dividends, bonuses, and foreign investments for banks under regulatory forbearance 

June 14, 2025
EFCC: Achimugu’s case unrelated to Atiku, Sanwo-Olu, agency says

EFCC arraigns SunTrust Bank MD, Executive Director over alleged $12 million money laundering 

June 13, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics